Scholars@Duke publication: Treatment of melanoma with a combination of type I and type II interferons results in growth ingibition and the induction of apoptosis associated with the loss of microphthalmia transcription factor (Mitf) expression

Treatment of melanoma with a combination of type I and type II interferons results in growth ingibition and the induction of apoptosis associated with the loss of microphthalmia transcription factor (Mitf) expression

Publication , Conference

Huang, Z

Duke Scholars

Author Zhiqing Huang Obstetrics and Gynecology, Reproductive Sciences

Citation

APA

Chicago

ICMJE

MLA

NLM

Huang, Z. (n.d.). Treatment of melanoma with a combination of type I and type II interferons results in growth ingibition and the induction of apoptosis associated with the loss of microphthalmia transcription factor (Mitf) expression.

Huang, Zhiqing. “Treatment of melanoma with a combination of type I and type II interferons results in growth ingibition and the induction of apoptosis associated with the loss of microphthalmia transcription factor (Mitf) expression,” n.d.

Huang Z. Treatment of melanoma with a combination of type I and type II interferons results in growth ingibition and the induction of apoptosis associated with the loss of microphthalmia transcription factor (Mitf) expression. In.

Huang, Zhiqing. Treatment of melanoma with a combination of type I and type II interferons results in growth ingibition and the induction of apoptosis associated with the loss of microphthalmia transcription factor (Mitf) expression.